ENTITY
Frontage Holdings

Frontage Holdings (1521 HK)

60
Analysis
Health CareChina
Frontage Holdings Corporation operates as a biotechnology company. The Company offers clinical trials, bioequivalence studies, medical writing, and agrochemical services. Frontage Holdings serves customers in Hong Kong.
more
Refresh
25 May 2019 01:51

ECM Weekly (25 May 2019) - ESR Cayman, Hansoh Pharma, Tai Hing, China East Edu, Haitong UniTrust

Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...

Share
15 May 2019 18:23

Frontage Holdings IPO: Risk-Reward Is Favourable at the Low-End of Price Range

Frontage Holdings (1521 HK) has launched its Hong Kong IPO at a price range of HK$2.55-3.20 per share to raise HK$1.27-1.60 billion ($160-200...

Logo
766 Views
Share
15 May 2019 15:03

Frontage Holdings (方达控股) IPO: Reasonable Valuation & Quality Cornerstones

Frontage Holdings, a pre-clinical CRO arm of A-share listed Hangzhou Tigermed Consulting (300347 CH), started book building today to raise up to...

Logo
793 Views
Share
bullishLuckin Coffee
11 May 2019 13:08

ECM Weekly (11 May 2019) - AB InBev APAC, ELuckin, Aakash Edu, GSX Techedu, CSSC (HK) Shipping

Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...

Share
08 May 2019 15:36

Frontage Holdings IPO Preview: An Uncertain Transition

Frontage Laboratories Inc (1000371Z HK) is a global contract research organisation (CRO) which is backed by Hangzhou Tigermed Consulting (300347...

Logo
673 Views
Share
x